 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/604967
Global In Vitro Diagnostic Market Analysis
|
Description: |
With the rapidly diversifying diagnostic industry, the In Vitro Diagnostic (IVD) has evolved as a major contributing segment. Extensive scientific research and development, technological advancements, and rising government and private sector participation are facilitating the growth globally. Demographic parameters, such as increasing disease prevalence and high disposable income have also contributed to the development of IVD services industry, which was estimated to have reached around US$ 43 Billion in 2010.
According to our new research report “Global In Vitro Diagnostic Market Analysis”, the global IVD market is likely to grow at a CAGR of around 6% during 2011-2013 to reach around US$ 52 Billion by 2013-end. The industry, which has been witnessing innovative healthcare and diagnostic solutions, is anticipated to continue striving towards technological innovation and widening its spectrum in all dimensions.
The report analyzes the key segments in the IVD market, which has witnessed tremendous growth in the recent years. The developments in the point-of-care and molecular diagnostics segment are also found to be high. The research also observes that the increasing prevalence of chronic diseases and rising technological R&D are fuelling growth in these segments. It also studies how the rising healthcare spending across the globe would impact these segments, which are likely to witness robust growth in revenues.
Our report provides a comprehensive geographic segmentation of the IVD market globally. Through top countries’ profiles, the study elaborates the performance of the IVD market in these nations, key developments in recent times, and provides forecast for the industry. The developed countries have been performing well in the IVD industry, but a great potential also lies for the industry in developing countries.
The report finds that Companion Diagnostics and Nano-diagnostics are the emerging sectors in the IVD industry, in which the growth is being fuelled by extensive R&D and novel solutions. The report also discusses the profiles of the key players in the industry to provide an insight into the competitive landscape. |
|
Contents: |
1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview 3.1 Introduction 3.2 What is In Vitro Diagnostics? 3.3 Market Size and Growth
4. Market Drivers 4.1 Chronic and Infectious Diseases 4.2 New Technologies 4.3 Emerging Markets 4.4 Diversifying Applications 4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2013 5.1 Point-of-Care Diagnostics 5.2 Clinical Chemistry and Immunochemistry 5.3 Molecular Diagnostics 5.4 Microbiology 5.5 Hemostasis 5.6 Hematology 5.7 Immunohematology
6. Segmentation by Indication (Current & Future Scenario - 2013) 6.1 Diabetes 6.2 Cardiovascular 6.3 Cancer 6.4 HIV 6.5 Tuberculosis 6.6 Influenza
7. Geographical Segmentation (Current & Future Scenario - 2013) 7.1 North America 7.1.1 United States 7.1.2 Canada 7.2 Europe 7.2.1 Germany 7.2.2 France 7.2.3 Italy 7.2.4 United Kingdom 7.2.5 Spain 7.2.6 Other European Countries 7.3 Japan 7.4 Other Key Countries 7.4.1 China 7.4.2 India 7.4.3 Turkey 7.4.4 Brazil 7.4.5 Mexico
8. Consumer Behavior Analysis
9. Emerging Sectors 9.1 Companion Diagnostics/Theranostics 9.2 Nanodiagnostics
10. Recent Developments and M&As
11. Industry Restraints 11.1 Regulatory and Reimbursement Issues 11.2 R&D and Short Product Lifecycle 11.3 Cost Control
12. Competitive Landscape 12.1 Market Share of Top Players 12.2 Key Players 12.2.1 Roche Holding Ltd. 12.2.2 Abbott Laboratories 12.2.3 Siemens AG 12.2.4 Beckman Coulter 12.2.5 Ortho-Clinical Diagnostics
List of Tables
Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2010 Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013 Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2010) Table 5-4: Global - Share of Top Players in Microbiology Diagnostic Market (2010) Table 5-5: Global - Share of Top Players in Hemostasis Diagnostic Market (2009) Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$) Table 7-1: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2009 Table 12-1: Roche Holding Ltd. - Strengths & Weaknesses Table 12-2: Abbott Laboratories - Strengths & Weaknesses Table 12-3: Siemens AG - Strengths & Weaknesses Table 12-4: Beckman Coulter - Strengths & Weaknesses Table 12-5: Ortho-Clinical Diagnostics - Strengths & Weaknesses
List of Charts
Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008-2013 Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2010 Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2013 Figure 5-3: Global - Point of Care Diagnostic Market by Segment (%) Figure 5-4: Global - Point of Care Diagnostic Market by Distribution (%) Figure 5-5: Global - Point of Care Diagnostic Market (Billion US$), 2009-2013 Figure 5-6: Global - Clinical Chemistry & Immunochemistry Market (Billion US$), 2009-2013 Figure 5-7: Global - Share of Players in Molecular Diagnostic Market (2010) Figure 5-8: Global - Molecular Diagnostic Market (Billion US$), 2009-2013 Figure 5-9: Global - Microbiology Diagnostic Market (Billion US$), 2010-2013 Figure 5-10: Global - Hemostasis Diagnostic Market (Billion US$), 2010-2013 Figure 5-11: Global - Hematology Market (Billion US$), 2009-2013 Figure 5-12: Global - Immunohematology Diagnostic Market (Billion US$), 2009-2013 Figure 6-1: Global - Diabetic Population (Million), 2010 & 2030 Figure 6-2: Global - Diabetes Diagnostic & Therapies Market (Billion US$), 2009-2013 Figure 6-3: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2009-2013 Figure 6-4: Global - Cancer In Vitro Diagnostic Market (Billion US$), 2011-2013 Figure 6-5: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012 Figure 6-6: Global - Tuberculosis Diagnostic Market by Segment (%) Figure 6-7: Global - Tuberculosis Detection and Monitoring Market by Segment (%) Figure 6-8: Global - Influenza Diagnostic Market (Million US$), 2008-2013 Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2010 Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2013 Figure 7-3: US - Labs in IVD Market by Type (%) Figure 7-4: US - In Vitro Diagnostic Market (Billion US$), 2008-2013 Figure 7-5: Canada - In Vitro Diagnostic Market (Billion US$), 2009-2013 Figure 7-6: Europe - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-7: Europe - In Vitro Diagnostic Market by Country (%), 2009 Figure 7-8: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-9: Germany - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-10: France - In Vitro Diagnostic Reagents Market by Clinical Segment (%) Figure 7-11: France - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-12: Italy - In Vitro Diagnostic Market by Segment (%), 2008 Figure 7-13: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008 Figure 7-14: Italy - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-15: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-16: UK - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-17: Spain - In Vitro Diagnostic Market (Billion Euro), 2009-2013 Figure 7-18: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-19: Japan - Share of Players in In Vitro Diagnostic Market Figure 7-20: Japan - In Vitro Diagnostic Market (Billion Yen), 2009-2013 Figure 7-21: China - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-22: China - In Vitro Diagnostic Market (Billion US$), 2009-2013 Figure 7-23: India - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-24: India - In Vitro Diagnostic Market (Million US$), 2009-2013 Figure 7-25: Turkey - Share of Clinical Laboratories by Type Figure 7-26: Turkey - In Vitro Diagnostic Market (Million Euro), 2008-2013 Figure 7-27: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2009 Figure 7-28: Brazil - In Vitro Diagnostic Market (Million US$), 2009-2013 Figure 7-29: Mexico - In Vitro Diagnostic Market by Clinical Segment (%) Figure 7-30: Mexico - In Vitro Diagnostic Market (Million US$), 2008-2013 Figure 11-1: Global - R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%) Figure 12-1: Global - Share of Players in In Vitro Diagnostic Market Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2010 Figure 12-3: Abbott Laboratories - Diagnostic Products Sales (Million US$), 2007-2010 Figure 12-4: Siemens AG - Diagnostic Division Revenues (Million Euro), FY 2009 & FY 2010 Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2010 |
|
Companies Mentioned |
- Roche Holding Ltd.
- Abbott Laboratories
- Siemens AG
- Beckman Coulter
- Ortho-Clinical Diagnostics |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/604967
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 16/02/2012 16:46:21 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Global In Vitro Diagnostic Market Analysis
|
|
Web Address: |
http://www.researchandmarkets.com/reports/604967
|
|
Office Code: |
|
OC8IHINLSNNSS
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€1,207.00
|
|
CD ROM
|
|
€1,358.00 + EUR€ 50.00 Shipping/Handling *
|
|
Hard Copy
|
|
€1,358.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic (PDF)
- Enterprisewide
|
|
€1,660.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 16/02/2012 16:46:21
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|